SEC Form 4 · accession 0001104659-15-055457
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Quisel
Officer — SVP Gen. Counsel & Secretary
Period of report
Jul 30, 2015
Accepted (ET)
Aug 3, 2015 · 8:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 30, 2015 | M | 7,527 | $5.28 | A | 30,228 | D | |
| Common Stock | Jul 30, 2015 | M | 5,895 | $5.28 | A | 36,123 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $5.28 | Jul 30, 2015 | M | 7,527 | D | — | Dec 16, 2021 | Common Stock | 7,527 | 2,346 | D |
| Option to Purchase Common StockF1 | $5.28 | Jul 30, 2015 | M | 5,895 | D | — | Jun 7, 2022 | Common Stock | 5,895 | 6,250 | D |
Explanation of responses
- F1The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.